Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

603882 Guangzhou Kingmed Diagnostics Group

63.380
-0.970-1.51%
Closed 09/30 15:00 CCT
High
65.380
Open
64.070
Turnover
264.67M
Low
63.300
Pre Close
64.350
Volume
41.24K
Market Cap
29.61B
P/E(TTM)
10.56
52wk High
122.880
Shares
467.14M
P/E(Static)
13.34
52wk Low
57.510
Float Cap
29.41B
Bid/Ask %
-17.25%
Historical High
177.271
Shs Float
464.02M
Volume Ratio
0.99
Historical Low
8.044
Dividend TTM
1.28
Div Yield TTM
--
P/B
3.96
Dividend LFY
2.02%
Div Yield LFY
--
Turnover Ratio
0.89%
Amplitude
3.23%
Avg Price
64.180
Lot Size
100
Float Cap
29.41B
Bid/Ask %
-17.25%
Historical High
177.271
Shs Float
464.02M
Volume Ratio
0.99
Historical Low
8.044
Dividend TTM
1.28
Limit Up
70.790
P/B
3.96
Dividend LFY
2.02%
Limit Down
57.920
Turnover Ratio
0.89%
Amplitude
3.23%
Avg Price
64.180
Lot Size
100
Ask
22.06Klots
Bid
18.01Klots
Price Forecast

No Data

News

Comment

Company Overview More
The company is a high-tech service enterprise with third-party medical examination and pathological diagnosis business as the core, through the continuous accumulation of core resource advantages such as "big platform, big network, large service, large sample and big data". Committed to providing leading medical diagnostic information integration services for medical institutions at all levels throughout the country. Since the 1990s, the core entrepreneurial team of Jinyu Medicine has actively explored the operation mode of medical laboratory outsourcing service in China, creating a precedent in the domestic third-party medical laboratory industry. After years of development, it has become a market leader in the domestic third-party medical laboratory industry. The company's main business is clinical specialties, hematological diseases, neurological and clinical immune diseases and solid tumors and other key disease areas. Physical and chemical mass spectrometry test, genome test, pathological diagnosis, biochemical luminescence test, immunological test, other comprehensive tests and so on. Corporate Honor: it won the "2018 responsible Brand Award" at the 8th China Public Welfare Festival; the "2018 Social responsibility Health Public Welfare Poverty Alleviation contribution Award" at the "2018 New KuaiBao-New Spine and New Power" activity; and the "China County Hospital most influential discipline Co-Construction Award" at the China Health County Congress in 2018.
CEO: --
Market: --
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...